Researchers report on a multinational, early phase clinical trial evaluating a new targeted therapy for patients with metastatic or unresectable non-small cell lung cancer who have a specific genetic mutation: EGFR Ex20Ins.
source https://www.sciencedaily.com/releases/2021/08/210803105526.htm
Wednesday, 4 August 2021
Related Posts
Coronavirus lurks and lingers in nursing home patients’ rooms, study findsEven though most COVID-19 cases come from exposure to airborne coronav… Read More
ESR-STM on single molecules and molecule-based structuresResearchers extend single-atom electron spin resonance with STM from a… Read More
Researchers find benefits and drawbacks to two-step surgical approach for 'leaky heart valves'Patients with mitral and tricuspid valve regurgitation, a condition so… Read More
PFAS exposure, high-fat diet drive prostate cells’ metabolism into pro-cancer stateA high-fat diet synergizes with exposure to PFAS to change the metabol… Read More
Competing quantum interactions enable single molecules to stand upNanoscale machinery has many uses, including drug delivery, single-ato… Read More
Easternmost Roman aqueduct discovered in ArmeniaArchaeologists have discovered remains of a Roman arched aqueduct duri… Read More
0 comments: